Clinical trial

Early Prostate Cancer: Predicting Treatment Response

NCT03770351

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2017-01-01

PhaseN/A

Study timeline

Study start (actual)2017-01-01Date precision: month

Registry last updated2021-04-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Sponsors & collaborators

University of California, Irvinelead sponsor

University of California, Los Angelescollaborator

Cedars-Sinai Medical Centercollaborator

VA Medical Center-West Los Angelescollaborator

VA Long Beach Healthcare Systemcollaborator

Mapped research locations

Los AngelesCalifornia, United States2 Long BeachCalifornia, United States1 IrvineCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03770351 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.